Item 5. Market for Registrant’s Common Equity
ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is traded on the NASDAQ Stock Market under the symbol “VTRS”. As of February 23, 2026, there were approximately 87,770 holders of record of shares of Viatris common stock.
The Company paid quarterly cash dividends of $0.12 per share on the Company’s issued and outstanding common stock in March 2025, June 2025, September 2025 and December 2025. On February 23, 2026, the Company’s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company’s issued and outstanding common stock, which will be payable on March 18, 2026 to shareholders of record as of the close of business on March 9, 2026. The declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. The Company also paid quarterly cash dividends of $0.12 per share on the Company’s issued and outstanding common stock in each of the four quarters of 2024 and 2023.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Viatris Inc.
Issuer purchases of equity securities
Period Total Number of Shares Purchased (a) (b)
Average Price Paid per Share (c)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a) (b)
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a)
October 1 - October 31, 2025
7,126,338 $ 10.14 7,126,338 $ 1,009,421,070
November 1 - November 30, 2025
928,388 10.65 928,388 999,532,092
December 1 - December 31, 2025
— — — 999,532,092
Total 8,054,726 $ 10.20 8,054,726 $ 999,532,092
____________
(a) Refer to Part II, Item 7. Management’s Discussion and Analysis of Financial Condition And Results of Operations – Recent Developments of this Form 10-K for additional information regarding the Company’s authorized share repurchase program. During the three months ended December 31, 2025, the Company repurchased approximately 8.1 million shares of common stock at a cost of approximately $82.1 million under this program.
(b) The number of shares purchased is based on the purchase date and not the settlement date.
(c) Average price per share includes commissions.
56
Table of Contents
STOCK PERFORMANCE GRAPH
The graph below compares Viatris Inc.’s cumulative total shareholder return on common stock with the cumulative total returns of the S&P 500 index and the Dow Jones US Pharmaceuticals index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from December 31, 2020 to December 31, 2025.
December 31,
2020 December 31,
2021 December 31,
2022 December 31,
2023 December 31,
2024 December 31,
2025
Viatris Inc. 100.00 73.87 63.32 64.63 77.34 81.26
S&P 500 100.00 128.71 105.40 133.10 166.40 196.16
Dow Jones U.S. Pharmaceuticals 100.00 124.98 134.76 134.75 145.47 185.97
ITEM 6. [Reserved]